Flossbach Von Storch’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Flossbach Von Storch's PFE Position: Q3 2017 in Review
Flossbach Von Storch sold out of Pfizer (PFE) in Q3 2017, closing a stake of 29,923 shares — an estimated $954K sold.
Flossbach Von Storch first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $134M in Q4 2013. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Flossbach Von Storch reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
- Flossbach Von Storch sold 29,923 Pfizer shares in Q3 2017, an estimated $954K.
- Flossbach Von Storch first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
- Flossbach Von Storch's Pfizer position peaked at $134M in Q4 2013.
- 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Flossbach Von Storch's 13F filing for Q3 2017, filed 9 Nov 2017.